▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Kody Kester

TMFkodyk123

Recent Articles by Kody Kester

Two people check their investments.

Sep 7, 2023 by Kody Kester

Looking to Build Wealth? Buy This Growth Stock

The retailer plans on opening an additional 2,000 stores between now and 2030.

A person shops at a supermarket.

Sep 7, 2023 by Kody Kester

Should You Buy This Blue Chip Dividend Stock for a Plateful of Income?

The consumer staples' products are in most U.S. households.

Berkshire Hathaway chief executive officer, Warren Buffett.

Sep 6, 2023 by Kody Kester

2 Warren Buffett Stocks to Buy Hand Over Fist in September

Warren Buffett's holding company owns stakes in these two blue chip stocks.

A person speaks to their doctor.

Sep 5, 2023 by Kody Kester

Could This Biosimilar Drug Be Novartis' Next Blockbuster?

Novartis expects to submit regulatory applications for its biosimilar soon.

A person relaxing on a sofa.

Sep 4, 2023 by Kody Kester

Buy This Superstar Dividend Growth Stock and Thank Yourself Later

The upscale home retailer has doubled its dividend in just the last five years.

A veterinarian examines a cat.

Sep 2, 2023 by Kody Kester

Trupanion's Membership Is Soaring. Should You Buy the Stock?

The pet health insurer could soon be generating positive free cash flow.

A doctor examines a patient.

Sep 2, 2023 by Kody Kester

Is This Underfollowed Genetic Diagnostics Stock a Buy for Growth Investors?

The genetic test maker is rapidly increasing test volumes.

A customer shops at a home improvement store.

Sep 1, 2023 by Kody Kester

Should You Buy This Blue Chip Dividend Stock for Your Portfolio?

The home improvement retailer held up relatively well in a challenging macroeconomic environment.

Two people shop at a clothing store.

Sep 1, 2023 by Kody Kester

Should Dividend Investors Buy Ross Stores Stock?

The retailer hooks its customers up with great merchandise at even better price points.

A healthcare professional draws blood from a patient.

Sep 1, 2023 by Kody Kester

Looking for Dividend Growth? Buy This Little-Known Healthcare Stock

The healthcare company's dividend has soared in recent years.

A doctor takes a patient's blood pressure.

Aug 31, 2023 by Kody Kester

Is Medtronic Stock a Buy for Income Investors?

The medical devices giant has upped its payout for many decades.

A customer shops for pet food.

Aug 31, 2023 by Kody Kester

1 Incredible Stock to Buy for Rising Dividend Income

The retailer has proven itself to be a tremendous dividend grower and capital compounder.

A person looks in the mirror while holding a shirt.

Aug 28, 2023 by Kody Kester

Buy This Winning Dividend Growth Stock and Forget About It

This discount retailing conglomerate is a remarkable dividend grower.

A person smokes a cigarette at a cafe

Aug 28, 2023 by Kody Kester

Looking for Huge Passive Income? This Stock Is a Blue-Chip Bargain

This tobacco giant offers a dividend yield in excess of 5%.

A customer shops at a pharmacy.

Aug 27, 2023 by Kody Kester

Is It Too Late to Buy Eli Lilly Stock?

Shares of the pharmaceutical company have crushed the market so far this year.

A doctor consults with their patient.

Aug 26, 2023 by Kody Kester

2 Healthcare Stocks That Could Help Make You a Fortune

These companies did well for shareholders over the last 10 years and have the potential to keep the growth going.

Customers wait in line at a fast food restaurant.

Aug 25, 2023 by Kody Kester

Is This Dividend Stock a No-Brainer Buy?

The parent company of Burger King is a leading restaurant franchise holding company.

A person shops online while holding a credit card.

Aug 25, 2023 by Kody Kester

Here's Why Mastercard Can Pay You for Years

The mega-cap payment processor has more growth ahead.

Young people shop for clothes.

Aug 24, 2023 by Kody Kester

Want Safe Income? This Stock Raised Its Dividend in the Last 4 Recessions.

The retail real estate investment trust has upped its payouts in all sorts of environments.

A patient attends a doctor appointment.

Aug 23, 2023 by Kody Kester

Could This Medicine Be the Next Winner for Novartis?

The Swiss drugmaker recently reported that a drug candidate met the primary endpoints in phase 3 clinical trials.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services